Estimated prevalence rates ranged from 22 percent for one to 14.8 percent for four or more
Significant declines seen across genders, races/ethnicities
Highest prevalence of experiencing four or more ACEs seen for females, non-Hispanic multiracial, gay or lesbian, bisexual, questioning
Findings seen for adolescent trauma patients who were American Indian, Black, Hispanic, female, Medicaid-insured, or uninsured
Associations appear to be stronger for White teens versus Black or Asian teens
Frequent use linked to higher prevalence of bullying victimization, persistent feelings of sadness or hopelessness
ACEs contribute substantially to suicide attempts, seriously considering attempting suicide, prescription opioid misuse
Warnings for youth resulted in marked increases in psychotropic drug poisonings and suicide deaths
Highest rates seen during COVID-19 pandemic versus before pandemic and in females, those aged 14 to 17 and 18 to 22 years
Findings seen for attention-deficit/hyperactivity disorder or depressive disorder